欧洲-话题@MedSci

#欧洲#

592篇内容 | 6123人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1339462, encodeId=9cc9133946205, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, objectTitle=甲亢治疗中最易被忽略的一环！《2021年欧洲Graves眼病临床实践管理指南》解读, objectType=article, longId=735191, objectId=e73fe3519133, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e73fe3519133, replyNumber=0, likeNumber=77, createdTime=2022-08-09, rootId=0, userName=ms9474365431325850, userId=5c442500150, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e73fe3519133, moduleTitle=甲亢治疗中最易被忽略的一环！《2021年欧洲Graves眼病临床实践管理指南》解读, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e73fe3519133)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339463, encodeId=dd4b13394632a, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, objectTitle=肥胖与高血压是“难兄难弟”！欧洲少年儿童高血压共识, objectType=article, longId=733889, objectId=9cd6e33889bc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9cd6e33889bc, replyNumber=0, likeNumber=126, createdTime=2022-07-31, rootId=0, userName=ms9474365431325850, userId=5c442500150, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9cd6e33889bc, moduleTitle=肥胖与高血压是“难兄难弟”！欧洲少年儿童高血压共识, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9cd6e33889bc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339461, encodeId=61771339461b1, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, objectTitle=2022欧洲科学院院士名单公布！这些国内院校医学专家入选, objectType=article, longId=733844, objectId=f531e338448e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f531e338448e, replyNumber=0, likeNumber=134, createdTime=2022-07-30, rootId=0, userName=ms9474365431325850, userId=5c442500150, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f531e338448e, moduleTitle=2022欧洲科学院院士名单公布！这些国内院校医学专家入选, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f531e338448e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339460, encodeId=68f1133946004, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, objectTitle=AOP Health在2022年欧洲血液学协会年会上公布CONTINUATION-PV研究的最终结果——BESREMi®（罗培根干扰素α-2b）治疗真性红细胞增多症患者长达7.5年, objectType=article, longId=730162, objectId=903de30162e2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=903de30162e2, replyNumber=0, likeNumber=162, createdTime=2022-06-23, rootId=0, userName=ms9474365431325850, userId=5c442500150, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=903de30162e2, moduleTitle=AOP Health在2022年欧洲血液学协会年会上公布CONTINUATION-PV研究的最终结果——BESREMi®（罗培根干扰素α-2b）治疗真性红细胞增多症患者长达7.5年, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=903de30162e2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339459, encodeId=c36f13394592b, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, objectTitle=综述：2022年欧洲克罗恩和结肠炎组织（ECCO）会议进展, objectType=article, longId=729676, objectId=efede29676da, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=efede29676da, replyNumber=0, likeNumber=119, createdTime=2022-06-17, rootId=0, userName=ms9474365431325850, userId=5c442500150, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=efede29676da, moduleTitle=综述：2022年欧洲克罗恩和结肠炎组织（ECCO）会议进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=efede29676da)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339458, encodeId=f22d1339458fd, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, objectTitle=基因测序证实猴痘已在欧洲发生大规模社区传播，多国拉响警报, objectType=article, longId=728303, objectId=a356e28303e6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a356e28303e6, replyNumber=0, likeNumber=91, createdTime=2022-06-01, rootId=0, userName=ms9474365431325850, userId=5c442500150, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a356e28303e6, moduleTitle=基因测序证实猴痘已在欧洲发生大规模社区传播，多国拉响警报, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a356e28303e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339457, encodeId=ae30133945ee6, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, objectTitle=指南共识 | 2021年欧洲指南：成人和儿童患者氢和甲烷呼气试验的适应证、表现和临床影响, objectType=article, longId=728005, objectId=47e6e28005e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=47e6e28005e3, replyNumber=0, likeNumber=92, createdTime=2022-05-29, rootId=0, userName=ms9474365431325850, userId=5c442500150, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=47e6e28005e3, moduleTitle=指南共识 | 2021年欧洲指南：成人和儿童患者氢和甲烷呼气试验的适应证、表现和临床影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=47e6e28005e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339456, encodeId=ca14133945627, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, objectTitle=「生气」如何一步步诱发心梗？《欧洲心脏杂志》找到了真凶, objectType=article, longId=727083, objectId=527ae2708390, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=527ae2708390, replyNumber=0, likeNumber=84, createdTime=2022-05-18, rootId=0, userName=ms9474365431325850, userId=5c442500150, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=527ae2708390, moduleTitle=「生气」如何一步步诱发心梗？《欧洲心脏杂志》找到了真凶, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=527ae2708390)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339455, encodeId=aa871339455e8, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, objectTitle=Rhizen Pharmaceuticals AG在2022年欧洲肿瘤内科学会乳腺癌会议上公布一项进行中的Tenalisib (RP6530)治疗局部晚期或转移性乳腺癌患者II期研究的中期积极数据, objectType=article, longId=726291, objectId=eddae262914c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eddae262914c, replyNumber=0, likeNumber=140, createdTime=2022-05-08, rootId=0, userName=ms9474365431325850, userId=5c442500150, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eddae262914c, moduleTitle=Rhizen Pharmaceuticals AG在2022年欧洲肿瘤内科学会乳腺癌会议上公布一项进行中的Tenalisib (RP6530)治疗局部晚期或转移性乳腺癌患者II期研究的中期积极数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eddae262914c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339454, encodeId=0abf133945459, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, objectTitle=欧洲药品管理局：mRNA新冠疫苗与自身免疫性肝炎无关, objectType=article, longId=725578, objectId=dbede2557809, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dbede2557809, replyNumber=0, likeNumber=136, createdTime=2022-04-29, rootId=0, userName=ms9474365431325850, userId=5c442500150, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dbede2557809, moduleTitle=欧洲药品管理局：mRNA新冠疫苗与自身免疫性肝炎无关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dbede2557809)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339453, encodeId=3ec8133945306, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, objectTitle=欧洲儿童肝炎集中爆发，专家称病因不明，与新冠疫情有一定关系, objectType=article, longId=724960, objectId=eb30e2496034, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eb30e2496034, replyNumber=0, likeNumber=95, createdTime=2022-04-27, rootId=0, userName=ms9474365431325850, userId=5c442500150, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eb30e2496034, moduleTitle=欧洲儿童肝炎集中爆发，专家称病因不明，与新冠疫情有一定关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eb30e2496034)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339452, encodeId=0147133945299, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, objectTitle=Alvotech和STADA与艾伯维解决欧洲专利纠纷，为Humira®的无柠檬酸盐、高浓度生物仿制药HUKYNDRA®(AVT02)上市铺平道路, objectType=article, longId=723787, objectId=0b3be23787cf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0b3be23787cf, replyNumber=0, likeNumber=0, createdTime=2022-04-09, rootId=0, userName=ms9474365431325850, userId=5c442500150, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0b3be23787cf, moduleTitle=Alvotech和STADA与艾伯维解决欧洲专利纠纷，为Humira®的无柠檬酸盐、高浓度生物仿制药HUKYNDRA®(AVT02)上市铺平道路, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0b3be23787cf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339450, encodeId=515213394501a, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, objectTitle=ARD：2021年欧洲风湿病学协会联盟/美国风湿病学会诊断和管理自身炎症I型干扰素病（CANDLE/PRAAS、SAVI和AGS）应考虑的要点, objectType=article, longId=723472, objectId=10a2e234729d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=10a2e234729d, replyNumber=0, likeNumber=76, createdTime=2022-04-05, rootId=0, userName=ms9474365431325850, userId=5c442500150, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=10a2e234729d, moduleTitle=ARD：2021年欧洲风湿病学协会联盟/美国风湿病学会诊断和管理自身炎症I型干扰素病（CANDLE/PRAAS、SAVI和AGS）应考虑的要点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=10a2e234729d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339451, encodeId=c3ad13394519b, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, objectTitle=再迎出海里程碑，百泽安®肺癌和食管癌上市许可申请获欧洲药品管理局受理, objectType=article, longId=301671, objectId=94873016e162, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=94873016e162, replyNumber=0, likeNumber=102, createdTime=2022-03-27, rootId=0, userName=医者仁心, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=94873016e162, moduleTitle=再迎出海里程碑，百泽安®肺癌和食管癌上市许可申请获欧洲药品管理局受理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=94873016e162)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339449, encodeId=e194133944921, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, objectTitle=Eur J Endocrinol:欧洲人群产前使用地塞米松治疗经典21-羟化酶缺乏症, objectType=article, longId=301460, objectId=6741301460b1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6741301460b1, replyNumber=0, likeNumber=80, createdTime=2022-03-24, rootId=0, userName=ms9474365431325850, userId=5c442500150, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6741301460b1, moduleTitle=Eur J Endocrinol:欧洲人群产前使用地塞米松治疗经典21-羟化酶缺乏症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6741301460b1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339448, encodeId=e43413394486b, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, objectTitle=Allergy：欧洲变应性鼻炎的用药模式如何？一款应用程序MASK-air®的真实数据揭晓答案, objectType=article, longId=301110, objectId=9567301110e5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9567301110e5, replyNumber=0, likeNumber=96, createdTime=2022-03-20, rootId=0, userName=ms9474365431325850, userId=5c442500150, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9567301110e5, moduleTitle=Allergy：欧洲变应性鼻炎的用药模式如何？一款应用程序MASK-air®的真实数据揭晓答案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9567301110e5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339447, encodeId=907c133944e2f, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, objectTitle=2022年3月17日简报：此轮本土传播以奥密克戎BA.2亚型为主，绝大多数为无症状感染；韩国日增40万例，死亡164人；BA.2株导致欧洲多国疫情反弹, objectType=article, longId=300998, objectId=058030099824, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=058030099824, replyNumber=0, likeNumber=92, createdTime=2022-03-18, rootId=0, userName=ms9474365431325850, userId=5c442500150, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=058030099824, moduleTitle=2022年3月17日简报：此轮本土传播以奥密克戎BA.2亚型为主，绝大多数为无症状感染；韩国日增40万例，死亡164人；BA.2株导致欧洲多国疫情反弹, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=058030099824)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339446, encodeId=29711339446b6, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, objectTitle=ARD:2022年美国风湿病学会/欧洲风湿病学会联盟显微镜下多血管炎分类标准, objectType=article, longId=300646, objectId=439b30064665, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=439b30064665, replyNumber=0, likeNumber=88, createdTime=2022-03-14, rootId=0, userName=ms9474365431325850, userId=5c442500150, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=439b30064665, moduleTitle=ARD:2022年美国风湿病学会/欧洲风湿病学会联盟显微镜下多血管炎分类标准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=439b30064665)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339445, encodeId=d09e1339445f4, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, objectTitle=2022年3月11日简报：本土连续新冠病毒感染超500人；德国韩国日增均超30万，均创新高，欧洲多国疫情重新抬头；日本预计今夏开放第四剂新冠疫苗接种, objectType=article, longId=300493, objectId=748f300493a9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=748f300493a9, replyNumber=0, likeNumber=151, createdTime=2022-03-12, rootId=0, userName=ms9474365431325850, userId=5c442500150, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=748f300493a9, moduleTitle=2022年3月11日简报：本土连续新冠病毒感染超500人；德国韩国日增均超30万，均创新高，欧洲多国疫情重新抬头；日本预计今夏开放第四剂新冠疫苗接种, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=748f300493a9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339444, encodeId=767b133944411, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, objectTitle=ARD：2022 美国风湿病学会/欧洲风湿病学协会联盟嗜酸性肉芽肿伴多血管炎分类标准, objectType=article, longId=299600, objectId=11e12996003d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=11e12996003d, replyNumber=0, likeNumber=95, createdTime=2022-02-26, rootId=0, userName=ms9474365431325850, userId=5c442500150, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=11e12996003d, moduleTitle=ARD：2022 美国风湿病学会/欧洲风湿病学协会联盟嗜酸性肉芽肿伴多血管炎分类标准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=11e12996003d)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

欧洲

2020-05-29

ms9474365431325850 (审核中...)

前往app查看评论内容

#欧洲#

甲亢治疗中最易被忽略的一环！《2021年欧洲Graves眼病临床实践管理指南》解读

2022-08-09

ms9474365431325850 (审核中...)

前往app查看评论内容

#欧洲#

肥胖与高血压是“难兄难弟”！欧洲少年儿童高血压共识

2022-07-31

ms9474365431325850 (审核中...)

前往app查看评论内容

#欧洲#

2022欧洲科学院院士名单公布！这些国内院校医学专家入选

2022-07-30

ms9474365431325850 (审核中...)

前往app查看评论内容

#欧洲#

AOP Health在2022年欧洲血液学协会年会上公布CONTINUATION-PV研究的最终结果——BESREMi®（罗培根干扰素α-2b）治疗真性红细胞增多症患者长达7.5年

2022-06-23

ms9474365431325850 (审核中...)

前往app查看评论内容

#欧洲#

综述：2022年欧洲克罗恩和结肠炎组织（ECCO）会议进展

2022-06-17

ms9474365431325850 (审核中...)

前往app查看评论内容

#欧洲#

基因测序证实猴痘已在欧洲发生大规模社区传播，多国拉响警报

2022-06-01

ms9474365431325850 (审核中...)

前往app查看评论内容

#欧洲#

指南共识 | 2021年欧洲指南：成人和儿童患者氢和甲烷呼气试验的适应证、表现和临床影响

2022-05-29

ms9474365431325850 (审核中...)

前往app查看评论内容

#欧洲#

「生气」如何一步步诱发心梗？《欧洲心脏杂志》找到了真凶

2022-05-18

ms9474365431325850 (审核中...)

前往app查看评论内容

#欧洲#

Rhizen Pharmaceuticals AG在2022年欧洲肿瘤内科学会乳腺癌会议上公布一项进行中的Tenalisib (RP6530)治疗局部晚期或转移性乳腺癌患者II期研究的中期积极数据

2022-05-08

ms9474365431325850 (审核中...)

前往app查看评论内容

#欧洲#

欧洲药品管理局：mRNA新冠疫苗与自身免疫性肝炎无关

2022-04-29

ms9474365431325850 (审核中...)

前往app查看评论内容

#欧洲#

欧洲儿童肝炎集中爆发，专家称病因不明，与新冠疫情有一定关系

2022-04-27

ms9474365431325850 (审核中...)